Published in Gene Therapy Weekly, March 23rd, 2006
The collaboration will bring together the expertise of both companies in miRNA and utilize Rosetta's database of novel miRNA genes and Isis' expertise in oligonucleotide chemistry and antisense drug discovery and development.
MicroRNAs are naturally expressed small RNAs that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.